AGN-241751 in the Treatment of Major Depressive Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The purpose of this study is to evaluate the efficacy and safety of AGN‐241751 in participants with Major Depressive Disorder
Epistemonikos ID: 0fa6d00b98b6f5ce89214776db9ca232aec582f8
First added on: May 21, 2024